Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 14 November 2018 (Status as of 1 January 2020)


Open article in different language:  DE  |  FR  |  IT
Art. 19 Import of non-authorised medicinal products for clinical trials

1 The im­port of medi­cin­al products for use in a clin­ic­al tri­al in ac­cord­ance with the pro­tocol for that tri­al re­quires a li­cence is­sued by Swiss­med­ic. This li­cence also cov­ers the in­di­vidu­al im­port of im­mun­o­lo­gic­al medi­cin­al products and of blood and blood products.

2 A li­cence is not re­quired if the im­port­ing per­son or in­sti­tu­tion already holds a li­cence as de­scribed in Art­icle 11.

Previous article Show article in the law Next article

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Gesetzeskürzel Name
DE FR IT EN
DE FR IT EN
Laden